India Regulatory pathway: Duniya SanoStem plans to pursue the applicable DCGI/CDSCO pathway for clinical research, import, manufacturing, and future authorization steps for SanoMSC, subject to regulatory review and approvals.
UAE / Dubai pathway: Duniya SanoStem plans to pursue applicable UAE and Dubai health authority pathways for clinical, hospital, manufacturing, and future commercialization planning, subject to local regulatory review and approvals.